Antiviral Vaccine/Drug R&D Platform
Platform for Animal Experiments and Safety Evaluation
Functionality:Covering the needs of animals such as mice, rats, guinea pigs, rabbits, dogs, pigs, and monkeys, providing technical support for pharmacological and pharmacokinetic evaluation.
Layout:Barrier environment of rodent experimental facilities, medium-sized animal experimental facilities (including ABSL-2 laboratories), and equipment for in vivo animal testing and analysis.
Analysis and Detection Platform
Functionality:Drug quality control and analysis, pharmacokinetic analysis.
Layout:Rapid discovery of emerging infectious pathogens, identification of drug efficacy, evaluation of vaccine protective effects.
Laboratories and Functional Zones
- Total area of facilities in use: 16000㎡
- ① Large Animal Area: Capable of accommodating ≥840 monkeys or ≥250 dogs (or pigs)
- ② Small Animal Barrier System: Capable of accommodating 8,000 rats or 20,000 mice
- ③ Small Animal Conventional Area: Capable of accommodating 1,100 rabbits or 2,400 guinea pigs
- Area awaiting renovation: 22,000㎡
First Floor
- Functional Laboratories
- South Zone: Test article room, bioanalysis room
- North Zone: Clinical pathology room, Ames pathology room, P2 laboratory, etc.
Second Floor
- South Zone: Conventional dog/pig rearing area
- North Zone: Conventional rabbit/guinea pig rearing area
Third Floor
- South Zone: Conventional monkey rearing area
- North Zone: SPF rat and mouse rearing area
Fourth Floor
- South Zone: Conventional dog rearing area
- North Zone: SPF rat and mouse rearing area
Instruments and Equipment